The microfluidic approach offered by this invention eliminates the problem of diffusion-based antibody-antigen binding interactions, and offers shorter reaction times. Furthermore, this invention uses small sample volumes that do not need prior purification.
[更多]
| |< <- | [3121] [3122] [3123] [3124] [3125] [3126] [3127] [3128] [3129] [3130] [3131] |
